Duke Cancer Institute
You are here
Location Info
Duke Cancer Institute
Duke Blood Cancer Center
Duke Blood Cancer Center
2400 Pratt St., Suite 5000,
Durham, NC 27705
Durham, NC 27705
Phone number: (919) 668-1002
Background data
Program type: Adult Program
FACT Approved: Yes
Year CAR T-cell Therapy Program Opened: 2018
CAR T-cell therapies performed
Year | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Number Performed | 35 | 27 | 41 | 75 |
Medical Director
Name | Phone |
---|---|
Mitchell Horwitz, MD | (919) 668-1000 |
Physician
Name | Phone |
---|---|
Taewoong Choi, MD | (919) 668-1000 |
Mitchell Horwitz, MD | (919) 668-1000 |
Chenyu Lin, MD | (919) 668-1000 |
Matthew McKinney, MD | (919) 668-1000 |
Sendhilnathan Ramalingam, MD | (919) 668-1000 |
Andrea Sitlinger, MD | (919) 668-1000 |
Alexandra Stefanovic, MD | (919) 668-1000 |
Jie Wang, MD | (919) 668-1000 |
Coordinator
Name | Phone |
---|---|
Lauren Jones, RN, BSN, OCN | (919) 668-3432 |
Krista Rowe, RN, MSN, AOCNS | (919) 684-7115 |
Social Worker
Name | Phone |
---|---|
Maurisa Darby, LCSW | (919) 668-6232 |
Kristen Evans, MSS, LCSW | (919) 668-4368 |
Bethany Henshall, LCSW | (919) 664-6680 |
Clara West, BSW |
Diseases treated by CAR T-cell therapy
- Leukemia, acute lymphoblastic
- Lymphoma
- Multiple Myeloma
CAR T-Cell products
- Abecma (idecabtagene vicleucil, ide-cel)
- Breyanzi (lisocabtagene maraleucel, liso-cel)
- Carvykti (ciltacabtagene autoleucel, cita-cel)
- Kymriah (tisagenlecleucel, tisa-cel)
- Tecartus (brexucabtagene autoleucel, brexu-cel)
- Yescarta (axicabtagene ciloleucel, axi-cel)